News Release - Eli Lilly and Company
WEBINDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound ® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand.
Lilly launches lower-price weight loss drug without injector pen - CNN
WEBAug 27, 2024 — The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that...
News Release - Eli Lilly and Company
WEBNov 8, 2023 — INDIANAPOLIS, Dec. 5, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Zepbound ™ (tirzepatide) injection is now available. Zepbound is indicated for adults with obesity (with a BMI of 30 kg/m 2 or greater), or those who are overweight (with a BMI of 27 kg/m 2 or greater) and also have weight-related medical ...
Eli Lilly to sell Zepbound directly to consumers without ... - ABC News
WEBAug 27, 2024 — Eli Lilly is now selling vials of Zepbound directly to consumers with a prescription. With insurance coverage, Zepbound can cost as low as $25 per month, but without coverage, the medication can cost more than $1,000 per month.
Zepbound price cut: Eli Lilly lowers cost of weight loss drug - NBC News
WEBAug 27, 2024 — Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply ...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
WEBNov 8, 2023 — The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
Eli Lilly slashes prices of weight-loss drug Zepbound for ... - CBS News
WEBAug 28, 2024 — Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the price of its pens, amid skyrocketing demand among Americans for...
Zepbound: FDA approves Eli Lilly’s diabetes drug Mounjaro for …
WEBNov 8, 2023 — The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss, according to a news release from the FDA. Made by Eli Lilly, it’s part of a new class of drugs that includes ...
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
WEBNov 9, 2023 — In clinical trials, Zepbound helped people lose, on average, 52 pounds, nearly rivaling the weight loss results achieved with bariatric surgery, according to Dr. Christopher McGowan, a ...
Zepbound: Eli Lilly releases new, cheaper form of weight loss drug
WEBAug 27, 2024 — Eli Lilly is offering 2.5-milligram and 5-milligram single-dose vials of Zepbound for $399 per month and $549 per month, respectively.